期刊文献+

光动力疗法对人肝癌细胞SSMC-7721凋亡及suivivin表达的影响

Effect of Photodynamic Therapy with Hematoporphyrin Derivative in the Apoptosis of Human Hepatocellular Carcinoma Cell line SMMC-7721 and the Expression of Survivin
原文传递
导出
摘要 目的:探讨血卟啉衍生物(hematoporphyrin derivative,HPD)光动力作用(photodynamic therapy,PDT)诱导人肝癌细胞SMMC-7721凋亡的作用及其机制。方法:采用MTT法测定PDT对人肝癌细胞的相对抑制率,并筛选最佳实验参数。应用流式细胞术检测PDT后细胞凋亡率。并用细胞免疫组化法检测survivin及caspase-3蛋白表达水平。结果:当HPD浓度为4mg/L,光照剂量为10J/cm2时,实验效果最佳,PDT光动力组人肝癌细胞SMMC-7721相对抑制率为(64.28±2.73)%,凋亡率达(35.28±1.52)%,与对照组相比,差异有显著意义(P<0.01);PDT后survivin蛋白表达水平显著低于对照组(P<0.05),而caspase-3却高于对照组。结论:血卟啉衍生物光动力作用具有诱导人肝癌细胞SMMC-7721凋亡的生物学效应,其作用机制可能与光动力作用抑制凋亡调控蛋白survivin表达,并直接或间接促进caspase-3的表达,从而促进细胞凋亡。 Objective:To evaluate the effect of photodynamic therapy with hematoporphyrin derivative in the apoptosis of human hepatocellular carcinoma cell line SMMC-7721 and the mathion. Methods: the surviving rate of SMMC-7721 was analyzed by MTT assay after photodynamic therapy.The apoptosis was detected by flow cytometry with AnnexinV-FITC and Propidium Iodide staining. The expression of survivin and caspase-3 of SMMC-7721 cell was determined by immunocytochemistry and RT-PCR assay respectively. Results:The apoptotic rate of human hepatocellular carcinoma cell line SMMC-7721 after photodynamic therapy with hematoporphyrin was significantly increased , which was higher than that in the controls (P<0.05).The expression of survivin protein in SMMC-7721 matoporphyrin group was lower than that in the controls ( P<0.05) and no difference between the controls while the expression of caspase-3 SMMC-7721 matoporphyrin group was higher than the controls.Conclusion: Photodynamic therapy with hematoporphyrin might obviously induce apoptosis of SMMC-7721 cells by inhibiting the translational level of survivin gene while promoting caspase-3.
出处 《现代生物医学进展》 CAS 2009年第24期4666-4668,共3页 Progress in Modern Biomedicine
基金 南京市科技局基金发展项目(2006ZD0117)
关键词 光动力作用 人肝癌细胞 SURVIVIN蛋白 CASPASE-3蛋白 Photodynamic therapy SMMC-7721 survivin caspase-3
  • 相关文献

参考文献10

  • 1Frederieke H. van Duijnhoven MD, PhD,Jeroen P. Rovers MD, PhD,Kerstin Engelmann MD,Zdenko Krajina MD, PhD,Shaun F. Purkiss MS, FRCS,Frans A. N. Zoetmulder MD, PhD,Thomas J. Vogl MD, PhD,Onno T. Terpstra MD, PhD, FRCS.Photodynamic Therapy With 5,10,15,20-Tetrakis(m-Hydroxyphenyl) Bacteriochlorin for Colorectal Liver Metastases Is Safe and Feasible: Results From a Phase I Study[J]. Annals of Surgical Oncology . 2005 (10)
  • 2Khaled A. Hamdan M.R.C.S.(Edinb.),Iain S. Tait Ph.D.,Valerie Nadeau B.Sc.,Miles Padgett Ph.D.,Frank Carey M.D.,Robert J. Steele M.D..Treatment of Grade III Anal Intraepithelial Neoplasia With Photodynamic Therapy[J]. Diseases of the Colon & Rectum . 2003 (11)
  • 3Engelmann K,Mack MG,Eichler K,etal.Interstitial photodynamic laser therapy for liver metastases:first results of a clinical phase I-study. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin . 2003
  • 4Van Duunhoven FH,Rovers JP,Engelmannk,et al.Photodynamic therapy with5,10,15,20-tetrakis(mhydroxyphenyl)bacteriochlorin for colorectal liver me-tastases is safe and feasible:results from a phase I study. Annals of Surgical Oncology . 2005
  • 5Hamdan KA,Tait IS,Nadeau V,etal.Treatinent of gradeⅢanal intraepithelial neoPlasia with photodynamic therapy:report of a case. Diseases of the Colon and Rectum . 2003
  • 6Van Duunhoven FH,,Rovers JP,Engelmannk,et al.Photodynamic therapy with5,10,15,20-tetrakis(mhydroxyphenyl)bacteriochlorin for colorectal liver me-tastases is safe and feasible:results from a phase I study. Annals of Surgical Oncology . 2005
  • 7Tang PM,Chan JY,Au SW,etal.Pheophorbidea,an active compound isolated from Scutellaria barbata,possessesphotodynamic activities by inducing apoptosis in human hepatocellular carcinoma.. Cancer Biology and Therapy . 2006
  • 8Seitz G,Krause R,Fuchs J,Heitmann H, et al.In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin. Oncol . 2008
  • 9Given M,Scott M,Mc Grath JP,et al.The predictive of tumour markers CA 15-3, TPS and CEA in breast cancer recurrence. Pathologe . 2000
  • 10Idenoue S,Hirohashi Y,Torigoe T,et al.A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Clinical Cancer Research . 2005

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部